Boots Bite & Sting Relief 2 Years Plus Antihistamine Cream


Boots Bite & Sting Relief 2 Years Plus Antihistamine Cream

(Mepyramine Maleate)

From 2 years

Relieves pain, itching and swelling

20 g e

Read all of this carton for full instructions.

What this medicine is for

A soothing antihistamine cream for the relief of pain, itching and swelling caused by insect bites and stings, and nettle stings.

Before you use this medicine X Do not use: If you are allergic to any of the ingredients or other antihistamines If you have eczema or other skin conditions If you are pregnant or breastfeeding, unless your doctor tells you to On broken skin, sunburnt skin or on large areas of skin

Cetostearyl alcohol and lanolin may cause skin reactions (e.g. contact dermatitis).

How to use this medicine

Check the tube seal is not broken before first use. If it is, do not use the cream. Pierce tube seal with end of cap.

Apply to the skin only.

Adults and children of 2 years and over:

Smooth a very small amount on the affected area. Use the cream 2 or 3 times a day, for a maximum of 3 days.

Do not use on children under 2 years.

If a rash develops, or the condition gets worse, stop using the cream.

If symptoms do not go away talk to your doctor.

! If anyone accidentally swallows some:

Talk to a doctor straight away.

Possible side effects

Most people will not have problems.

If you get these side effects stop using the cream and see a doctor.

Allergic reaction (e.g. skin rash, red or itchy skin, worsening of the condition you are treating)

If you notice any side effect not listed here, please tell your pharmacist or doctor.

How to store this medicine

Do not store above 25°C.

Keep all medicines out of the sight and reach of children.

Use by the date on the end flap of the carton.

Active ingredient

This cream contains Mepyramine Maleate 2% w/w.

Also contains: purified water, cetostearyl alcohol, white soft paraffin, liquid paraffin, cetomacrogol 1000, anhydrous hypoallergenic lanolin, sorbitan sesquioleate, sodium citrate, citric acid monohydrate.

PL 00014/0440

Text prepared 2/07

Manufactured by the Marketing Authorisation holder The Boots Company PLC Nottingham NG2 3AA

If you need more advice ask your pharmacist.

BTC14991 vD 15-06-07


read more


Boots Antifungal Cream


Boots Antifungal Cream

(Clotrimazole)

for fungal infections of the skin

20 g

Read all of this carton for full instructions.

What this medicine is for

An antifungal cream for the treatment of fungal skin infections including ringworm, athlete’s foot, fungal nappy rash, infections of the armpit, groin, toes and skin folds and thrush of the vulva or penis.

Before you use this medicine Do not use: If you are allergic to any of the ingredients If you are pregnant or breastfeeding, unless your doctor or midwife tells you to

Information about some of the ingredients: The ingredients in the cream may affect the latex used in contraceptives such as condoms and diaphragms. This may reduce the effectiveness of the contraceptives. You should therefore use other methods of contraception for at least 5 days after using this medicine in the genital area. You may, for example, use a spermicide gel in addition to the condom or diaphragm. If you need more advice about this speak to your pharmacist.

Cetyl alcohol and stearyl alcohol in this medicine may cause skin reactions (e.g. contact dermatitis).

How to use this medicine

Check the tube seal is not broken before first use. If it is, do not use the cream.

Pierce tube seal with end of cap.

Adults and children: Apply to the affected area two or three times a day. Use the cream for at least 2 weeks. In some cases it may be necessary to continue to use the cream for more than 4 weeks.

If you are using the cream for a foot infection, make sure your feet, especially between the toes, are washed and thoroughly dried before applying the cream. Apply to the skin only.

Do not use more than the amount recommended above.

If symptoms do not go away talk to your doctor.

If anyone accidentally swallows some: Talk to a doctor straight away.

Possible side effects

Most people will not have problems, but some may get some.

If you get these side effects, stop using the cream and see a doctor: Allergic reaction (e.g. skin rash, red or itchy skin) These other effects are less serious. If they bother you talk to a pharmacist: Rarely, mild burning or irritation immediately after using the cream Pain

If any side effect becomes severe, or you notice any side effect not listed here, please tell your pharmacist or doctor.

Keep all medicines out of the sight and reach of children.

Use by the date on the end flap of the carton.

Active ingredient

This topical cream contains Clotrimazole 1% w/w.

Also contains: purified water, 2-octyldodecanol, stearyl alcohol, cetyl alcohol, cetyl esters wax, sorbitan stearate, polysorbate 60, benzyl alcohol.

PL 10622/0004 [P]

Text prepared 8/08

Manufactured for The Boots Company PLC Nottingham NG2 3AA

by

Thornton & Ross Ltd Linthwaite Huddersfield West Yorkshire HD7 5QH Marketing Authorisation held by PLIVA Pharma Ltd Vision House Bedford Road Petersfield Hampshire GU32 2QB

If you need more advice ask your pharmacist.

1498cXPil


read more


Boots Soothing Eye Drops


Boots Soothing Eye Drops

(Cetrimide, Hamamelis Water)

Soothing & antiseptic

10 ml e

Read all of this carton for full instructions.

Uses: A soothing and antiseptic sterile solution for the relief of minor eye irritation. It can be used to soothe eyes irritated by smoke and dust. Before you use this medicine Do not use: If you are allergic to any of the ingredients If you wear soft contact lenses

You can use this medicine if you are pregnant or breastfeeding.

How to use this medicine

Check the cap seal is not broken before first use. If it is, do not use the drops.

Tilt head back and hold down lower eye lid. Squeeze the bottle to put drops into the corner (lower sac) of the eye.

For use in the eyes only.

Age: Adults and children How much: One or two drops How often: Morning and night, or when you need to

If anyone accidentally swallows some: Talk to a doctor

Possible side effects

Most people will not have problems, but some may get some of these:

Red, swollen or itchy eyes (signs of allergic reaction) – if this happens stop using the drops

If any side effect becomes severe, or you notice any side effect not listed here, please tell your pharmacist or doctor.

Keep all medicines out of the sight and reach of children.

Use by the date on the end flap of the carton. Throw away any unused drops 28 days after first opening.

Active ingredients

These eye drops contain Cetrimide 0.01% w/v, Hamamelis Water 5% v/v.

Also contains: purified water, boric acid, borax.

PL 00014/5237

[P]

Text prepared 11/07

Manufactured for the Marketing Authorisation holder The Boots Company PLC Nottingham NG2 3AA

by

Hamol Limited Nottingham NG90 2DB

If you need more advice ask your pharmacist.

BTC16394 vE 28/02/08


read more


Boots Antiseptic Gel


Boots Antiseptic Gel

(Cetylpyridinium Chloride)

Prevents Infection Helps Healing Process Effective Cleansing Action

e 30 g

Read all of this carton for full instructions.

What this medicine is for

This medicine contains Cetylpyridinium Chloride which belongs to a group of medicines called antiseptics, which act to prevent infection.

It can be used on cuts, grazes, insect bites, minor wounds, spots, minor burns and scalds.

Before you use this medicine

Do not use:

If you are allergic to any of the ingredients On weeping or badly inflamed skin Frequently or for long periods of time (you may become sensitive to the medicine)

You can use this medicine if you are pregnant or breastfeeding.

How to use this medicine

Check the seal is not broken before first use. If it is, do not use the gel.

Apply to the skin only.

Avoid contact with the eyes.

Children and adults:

Apply to the affected area of skin 2 or 3 times a day.

Do not use more than the amount recommended above.

If the skin does not appear to heal talk to your doctor.

If anyone accidentally swallows some:

Talk to a doctor straight away.

Possible side effects

Most people will not have problems, but some may get some.

If you get any of these side effects, stop using the gel and see a doctor:

Allergic reaction (e.g. skin rash, red or itchy skin)

These other effects are less serious. If they bother you talk to a pharmacist:

Skin irritation

If any side effect becomes severe, or you notice any side effect not listed here, please tell your pharmacist or doctor.

Keep all medicines out of the sight and reach of children.

Use by the date on the end flap of the carton.

Active ingredient

This gel contains Cetylpyridinium Chloride 0.025% w/w.

Also contains: purified water, glycerol, hypromellose, sodium citrate, citric acid.

PL 00014/0556

Text prepared 3/07

Manufactured by the Marketing Authorisation holder The Boots Company PLC Nottingham NG2 3AA

If you need more advice ask your pharmacist.

BTC14517 vD 12-12-07


read more


Teruflex Blood Bag System


Generic Name: anticoagulant citrate phosphate dextrose (cpd) and as-5 red cell preservative
TERUFLEX® BLOOD BAG SYSTEM WITH BLOOD SAMPLING ARM® CPD/OPTISOL® SOLUTION Issued 8/96
TERUFLEX® BLOOD BAG SYSTEM With Blood Sampling Arm® CPD/OPTISOL® SOLUTION
Read these instructions carefully before use.
INSTRUCTIONS FOR BLOOD COLLECTION: Use aseptic technique
Materials Needed:
VENOJECT® ll Tube Holder (code P-1316R)
VENOJECT® ll Multi-Sample Luer Adapter (code MN *2000)
VENOJECT® ll Plastic Blood Collection Tubes (or equivalent glass or plastic evacuated blood collection tube)
1. Confirm that all numbered tubing of each blood bag unit contains segment numbers.
2. Make a loose knot in donor tubing below "Y" unless alternate methods are used to seal tubing.
3. Clamp donor tubing.
4. Suspend primary bag as far as possible below the donor's arm.
5. Apply blood pressure cuff or tourniquet to donor's arm. Disinfect site of phlebotomy. If blood pressure cuff is used, inflate cuff to approximately 60 mmHg.
6. Remove needle protector and perform phlebotomy. Remove clamp to permit blood flow into primary bag.
CAUTION Do not touch needle after removing the needle protector.
7. Appropriately secure donor tubing to donor's arm.
8. MIX BLOOD WITH ANTICOAGULANT AT SEVERAL INTERVALS DURING COLLECTION.
9. Collect labeled volume of blood (+/–10%).
10. Tighten knot firmly after collection. Clamp between knot and "Y". Sever donor tubing between the knot and clamp. Alternate methods may be used to seal tubing.
CAUTION Do not use the dielectric tube sealer while the needle is connected to the donor's body.
Anytime before Step #13 below, sever donor tubing between the two seals.
Collect blood samples as follows:
a) Connect VENOJECT II Multi-Sample Luer Adapter to VENOJECT II Tube Holder (Fig. 1).
b) Remove covers and connect multi-sample luer adapter to female luer at end of donor sampling tubing (Fig. 2).
c) Snap CLIKTIP in donor sampling tubing to open blood pathway.
Insert Fig. 1 here
Insert Fig. 2 here
d) Insert blood collection tube (VENOJECT II or equivalent) firmly into VENOJECT II Tube Holder : when full, remove sample tube from holder. Repeat to collect additional samples.
11. Reapply clamp to donor tubing between phlebotomy needle and "Y"; release pressure on donor's arm and remove needle.
CAUTION Discard tubing/phlebotomy needle unit according to institutional procedures.
12. Immediately after collection, invert bag several times to assure blood and anticoagulant are well mixed.
13. Strip blood from the donor tubing into bag, mix well, and allow tubing to refill. Seal on or near X marks on donor tubing to provide numbered aliquots of anticoagulated blood for testing.
14. The time of addition of OPTISOL Solution may vary depending on the processing option selected. Add the solution under one of the following conditions.
a) After removal of plasma from freshly collected blood.
b) Within 8 hours of blood collection if components are prepared.
c) Within 72 hours of collection if blood is refrigerated immediately following collection.
15. Centrifuge the unit to separate red cells from plasma.
16. Snap CLlKTIP (inline closure device) of primary collection bag and transfer plasma into satellite bag. Clamp transfer tubing of satellite bag.
17. Snap CLlKTIP of OPTlSOL Solution bag and drain contents into primary bag containing red blood cells. Seal tubing of primary bag in two places, and cut between seals and separate from satellite bag(s).
NOTE: For TERUFLEX double bags, seal OPTISOL Solution bag tubing in two places and cut between seals. Discard OPTISOL Solution container.
18. Invert the red cell- OPTISOL mixture several times to insure the final AS-5 red cell product is well suspended.
19. Store AS-5 Red Blood Cells between 1-6°C.
20. Infuse AS-5 Red Blood Cells within 42 days of collection.
For further processing, use standard component processing techniques.
To open blister package, peel cover film back four fifths of its length.
After opening, unused bags may be stored for 30 days by returning cover film to original position and sealing with tape to prevent possible loss of moisture.
Insert Fig. 3 here
CAUTIONS
•THE PACKET OF AGELESS CONTAINED IN THIS PACKAGE ABSORBS OXYGEN AND GENERATES HEAT ON REMOVAL AND SHOULD BE HANDLED WITH CARE.
• DISPOSE WITH PACKET IN TRAY.
• DO NOT DISPOSE WITH WASTES CONTAINING VOLATILE OR FLAMMABLE MATERIALS.
• DISCARD AGELESS PACKET WITHOUT OPENING.
TERUMO® TERUMO CORPORATION 44-1, 2-CHOME, HATAGAYA, SHIBUYA-KU, TOKYO, JAPAN
®: Registered Trademark
N-BB-OP-A(SP) 3


Tray/Case Label

TERUFLEX® BLOOD BAG SYSTEM with
BLOOD SAMPLING ARM®
CPD WITH OPTISOL® RED CELL PRESERVATIVE SOLUTION
FOR COLLECTION OF 500mL OF BLOOD
Each unit consists of a collection bag containing 70mL of Anticoagulant
CPD solution, with a satellite bag containing 111mL of OPTlSOL Red
Cell Preservative Solution.
Each 70mL Anticoagulant CPD solution USP contains 1.79g Dextrose
(monohydrate) USP, 1.84g Sodium Citrate (dihydrate) USP, 209mg Citric
Acid (anhydrous) USP, 156mg Monobasic Sodium Phosphate
(monohydrate) USP.
Each 111mL OPTISOL Red Cell Preservative Solution contains 974mg
Sodium Chloride USP, 1.00g Dextrose (monohydrate) USP, 583mg
Mannitol USP, 33.3mg Adenine USP.
STERILE, NON-PYROGENIC FLUID PATH.
DO NOT USE UNLESS ANTICOAGULANT IS CLEAR.
CODE
LOT No.
EXPIRY
UNITS
DONOR NEEDLE 16G x 1 1/2? (1.60 x 38mm)
Rx ONLY
RECOMMENDED STORAGE: Room Temperature (15-30°C/59-86°F).
Avoid excessive heat. Protect from freezing.
After opening, unused bags may be stored for 30 days by returning cover film to original
position and sealing with tape to prevent possible loss of moisture.
See Instructions For Blood Collection.
Manufactured by : TERUMO CORPORATION Tokyo, Japan
® : Registered Trademark
Blood Sampling Arm is a trademark of TERUMO CORPORATION.
Rev. 01/03
B-4-H6-A4 2
Place Label here



Teruflex Blood Bag System WITH BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RED CELL PRESERVATIVE 
anticoagulant citrate phosphate dextrose (cpd) and as-5 red cell preservative  kit Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 53877-009 Packaging # NDC Package Description Multilevel Packaging 1 53877-009-41 24 BAG In 1 CASE contains a BAG 1 1 KIT In 1 BAG This package is contained within the CASE (53877-009-41) QUANTITY OF PARTS Part # Package Quantity Total Product Quantity Part 1 1 BAG   70 mL Part 2 1 BAG   111 mL Part 1 of 2 ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD)  
anticoagulant citrate phosphate dextrose (cpd)  solution Product Information       Route of Administration INTRAVENOUS DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Trisodium Citrate Dihydrate (Citric Acid) Trisodium Citrate Dihydrate 26.3 g  in 1000 mL Sodium Phosphate, Monobasic (Phosphoric Acid) Sodium Phosphate, Monobasic 2.22 g  in 1000 mL Dextrose Monohydrate (Dextrose) Dextrose Monohydrate 25.5 g  in 1000 mL Anhydrous Citric Acid (Citric Acid) Anhydrous Citric Acid 2.99 g  in 1000 mL Inactive Ingredients Ingredient Name Strength Water   Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 70 mL In 1 BAG None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA880217 05/05/2010
Part 2 of 2 OPTISOL RED CELL PRESERVATIVE  
as-5 red cell preservative  solution Product Information       Route of Administration INTRAVENOUS DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Sodium Chloride (SODIUM CATION) Sodium Chloride 877 mg  in 100 mL Dextrose Monohydrate (Dextrose) Dextrose Monohydrate 900 mg  in 100 mL Mannitol (Mannitol) Mannitol 525 mg  in 100 mL Adenine (Adenine) Adenine 30 mg  in 100 mL Inactive Ingredients Ingredient Name Strength Water   Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 111 mL In 1 BAG None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA880217 05/05/2010
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA880217 05/05/2010
Labeler - Terumo Corporation (690543319) Establishment Name Address ID/FEI Operations Terumo Corp. - Fujinomiya Factory 695214015 manufacture Revised: 06/2011Terumo Corporation

read more


Sensodyne Original / Sensodyne Toothpaste: Original Flavour 10% w / w


1. Name Of The Medicinal Product

Sensodyne Original / Sensodyne Toothpaste: Original Flavour 10% w/w

2. Qualitative And Quantitative Composition

Strontium chloride hexahydrate, 10% w/w

3. Pharmaceutical Form

Toothpaste

4. Clinical Particulars 4.1 Therapeutic Indications

Relief from the pain of dentine sensitivity

4.2 Posology And Method Of Administration

To be used 2-4 times daily, in place of ordinary toothpaste

4.3 Contraindications

None

4.4 Special Warnings And Precautions For Use

Sensitive teeth may indicate an underlying problem which needs prompt care by a dentist.

Dental advice should be sought as soon as possible after the problem develops.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

None known

4.6 Pregnancy And Lactation

No adverse effects known

4.7 Effects On Ability To Drive And Use Machines

None known

4.8 Undesirable Effects

None known

4.9 Overdose

No symptoms of Sensodyne overdose are known.

5. Pharmacological Properties 5.1 Pharmacodynamic Properties

Dentine sensitivity results from exposure of dentinal tubules to external stimuli. The hydrodynamic theory proposes that fluid movement within tubules stimulates mechanoreceptors in or near the pulp, causing pain. It is postulated that Sensodyne Original relieves pain by reducing fluid movement by occlusion of the tubules.

5.2 Pharmacokinetic Properties

Sensodyne Original is applied topically and so the pharmacokinetics of strontium chloride hexahydrate are not relevant to its efficacy.

5.3 Preclinical Safety Data

None stated.

6. Pharmaceutical Particulars 6.1 List Of Excipients

Purified water

Glycerol

Sorbitol liquid (non-crystallising)

Calcium carbonate

Hydroxyethyl cellulose

Silica, colloidal anhydrous

Sodium methyl cocoyl taurate

Polyoxyl 40 stearate

Titanium dioxide

Sodium saccharin

F, D & C Red No.3 (E127, Erythrosine)

Flavour

Flavour mix constituents:

Spearmint oil

Peppermint oil

Levomenthol

Methyl salicylate

Oil of cassia

6.2 Incompatibilities

None known

6.3 Shelf Life

36 months

6.4 Special Precautions For Storage

Store below 25°C

6.5 Nature And Contents Of Container

Sensodyne Original will be packaged in the following containers and pack sizes.

Container Pack size (ml) Plastic laminate tube with full diameter cap and tamper evident nozzle seal 45, 50, 75, 100 Aluminium Barrier Laminate tube with full diameter cap 45, 50, 75, 100 Cross promotional pack containing plastic laminate tube and Sensodyne 75 6.6 Special Precautions For Disposal And Other Handling

Not appropriate

Administration Data 7. Marketing Authorisation Holder

Stafford Miller Limited

980 Great West Road

Brentford

Middlesex TW8 9GS

UNITED KINGDOM

Trading as: GlaxoSmithKline Consumer Healthcare, Brentford, TW8 9GS, UK

8. Marketing Authorisation Number(S)

PL 0036/5011R

9. Date Of First Authorisation/Renewal Of The Authorisation

23 April 1991

10. Date Of Revision Of The Text

27 March 2009


read more


Boots Heartburn Relief Aniseed Flavour (500ml)


Boots Heartburn Relief Aniseed Flavour

(Calcium Carbonate, Sodium Alginate, Sodium Bicarbonate)

For fast, effective relief of Heartburn and Acid Indigestion Sugar Free

e 500 ml

Read all of this label for full instructions.

Uses: This medicine contains an antacid to relieve the symptoms of indigestion and heartburn. It can be used for the relief of heartburn in pregnancy, and other conditions, which cause acid reflux.

Before you take this medicine Do not take: If you are allergic to any of the ingredients Talk to your pharmacist or doctor: If you are on a low salt (sodium) diet (each 5 ml spoonful contains 71 mg of sodium, which may be harmful to you) If you take other medicines ACE inhibitors (for high blood pressure) Quinidine (for heart problems) Medicines to treat infections or malaria Lithium (for mood disorders) Antipsychotics (for mental health conditions) Medicines for epilepsy Medicines for osteoporosis, pain or rheumatoid arthritis

Do not take this medicine within 1 to 2 hours of taking any other medicine.

Information about some of the ingredients: This medicine contains E214 and E216 which may cause allergic reactions such as skin rash (possibly delayed).

How to take this medicine

Check the cap seal is not broken before first use. If it is, do not take the medicine.

Shake the bottle well before use.

Adults and children of 12 years and over: Two to four 5 ml spoonfuls.
Children of 6 to 11 years: One or two 5 ml spoonfuls.
Swallow the medicine after meals and at bedtime.

Do not give to children under 6 years.

Do not take more than the amount recommended.

If symptoms do not go away within 2 weeks talk to your doctor.

If you take too much: You may get a bloated stomach. If this happens talk to your pharmacist or doctor.

Possible side effects

Most people will not have problems, but some may get some of these:

Constipation, wind, stomach cramps, burping

If any side effect becomes severe, or you notice any side effect not listed here, please tell your pharmacist or doctor.

How to store this medicine

Do not store above 25°C.

Do not refrigerate.

Keep all medicines out of the sight and reach of children.

Use by the date on the label edge.

Active ingredients

Each 5 ml of oral suspension contains Calcium Carbonate 80 mg, Sodium Alginate 250 mg, Sodium Bicarbonate 133.5 mg.

Also contains: carbomer, sodium hydroxide, saccharin sodium, ethyl hydroxybenzoate (E214), propyl hydroxybenzoate (E216), butyl hydroxybenzoate, isopropyl alcohol, erythrosine (E127), aniseed oil, purified water.

PL04917/0021

Text prepared 11/08

Manufactured for The Boots Company PLC Nottingham NG2 3AA by the Marketing Authorisation holder Pinewood Laboratories Limited Ballymacarbry Clonmel Co. Tipperary Ireland

If you need more advice ask your pharmacist

3581eMC


read more


Boots Effervescent Health Salts


Boots Effervescent Health Salts

(Magnesium Sulphate, Sodium Bicarbonate, Citric acid)

Sparkling relief of upset stomach, heartburn, indigestion and occasional constipation

227 g

Read all of this label for full instructions.

Uses: An antacid and laxative for the relief of upset stomach, heartburn, indigestion, feeling sick and for the relief of occasional constipation.

Before you take this medicine Do not take: If you are allergic to any of the ingredients If you have severe stomach problems If you have an intolerance to some sugars, unless your doctor tells you to (this medicine contains sucrose) Talk to your pharmacist or doctor: If you have heart, kidney or liver problems If you have diabetes If you need to use a laxative every day If you have severe stomach pain If you are elderly, or feel very weak If you are on a controlled sodium diet (each level teaspoon of powder contains 185 mg sodium) If you are pregnant or breastfeeding How to take this medicine

Check the inner seal is not broken before first use. If it is, do not use the powder.

Use a dry spoon to measure. Mix the amount in the table with a glass of water and drink the solution, before it stops fizzing. Replace lid firmly after use.

Adults:

For upset stomach, heartburn, indigestion, feeling sick: One or two teaspoonfuls.

For constipation: Two teaspoonfuls before breakfast or at bedtime.

Children of 3 years and over: Reduce the amount above according to size and age.

Do not give to children under 3 years.

Do not take this medicine for long periods of time (generally more than a week).

Do not take more than the amount recommended.

If symptoms worsen talk to your doctor. If symptoms don’t go away talk to your doctor.

Possible side effects

Most people will not have problems, but some may get some of these:

Gripping pain in your stomach Diarrhoea, feeling sick, being sick

If you have taken the medicine for a long time you may get:

Light headedness, confusion Muscle weakness, cramps Numbness, tingling, breathing problems

If any side effect becomes severe, or you notice any side effect not listed here, please tell your pharmacist or doctor.

Store in a dry place below 25°C and away from strong smells.

Keep all medicines out of the sight and reach of children.

Use by the date on the base of the tub. Throw away any powder left 3 months after opening.

Active ingredients: This effervescent powder contains Citric Acid 19.5% w/w, Magnesium Sulphate 17.4% w/w, Sodium Bicarbonate 22.6% w/w.

Also contains: sucrose.

PL12063/0039

Text prepared 4/08

Manufactured for

The Boots Company PLC Nottingham NG2 3AA

by the MA holder

Wrafton Laboratories Limited Braunton Devon EX33 2DL

If you need more advice ask your pharmacist.


read more


Fanatrex


gabapentin
Dosage Form: oral suspension - kit
Fanatrex Fanatrex Description

NDC 43093-105-01
Rx only
FusePaq™
Fanatrex™
(gabapentin 25 mg/mL, in oral suspension - kit)
FusePaq™ kits provide a convenient approach to rapidly prepare prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practices (cGMP).
Description:
This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin.  This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.
Contents:

10.5 g gabapentin, USP 420 mL oral suspension vehicle (water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, sodium benzoate, potassium sorbate, dibasic sodium phosphate) Disposable funnel Press-in bottle adaptor for oral dispenser Oral dispenser Instructions SUGGESTED PREPARATION

Suggested Preparation
Gabapentin, 25 mg/mL oral suspension


1    Remove and Inspect the Contents of the Kit
Remove kit contents. Ensure that seals are present and intact on the gabapentin and oral suspension vehicle bottles. If the seals are not intact, do not use the kit.


2    Prepare for Mixing
Wear gloves and eye protection during mixing operations. Remove the seal from the oral suspension bottle. Break the seal and remove the cap from the gabapentin bottle.


3    Transfer Gabapentin to the Suspension Bottle
Uncap the suspension bottle. Using the included funnel, carefully transfer the gabapentin powder to the suspension bottle. Cap the suspension bottle and mix thoroughly by inverting and shaking until all contents are dissolved. Uncap the suspension bottle. Pour a small amount of the mixed suspension back into the gabapentin bottle. Cap the gabapentin bottle and shake to ensure that all residual gabapentin has been dissolved. Pour the liquid through the funnel into the suspension bottle. Discard the funnel and gabapentin powder bottle.


4    Complete the Mixing Process
Insert the press-in bottle adaptor into the suspension bottle. Recap the suspension bottle. Mix well by inverting repeatedly several times. Visually ensure that all contents are dissolved.


5    Re-label the Suspension
Label the mixed suspension as required for prescription products. Ensure that the original oral suspension vehicle label is removed or obscured, since the original label is no longer accurate once the suspension is prepared.


Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the mixed suspension between 15-30°C (59-86°F). The mixed suspension is stable for at least eight weeks, based upon real-time and accelerated stability studies.

Each lot of suspension vehicle is tested to meet microbial limits per USP Microbial Limit Test <61>. In addition, the suspension vehicle formulation has passed the USP <51> Antimicrobial Effectiveness Test.
An oral dispenser is provided in the kit and may be used to facilitate delivery of the suspension.


U.S. Patents Pending


Manufactured by:
Fusion Pharmaceuticals, LLC
768 Calle Plano
Camarillo, CA 93012


CS75-A1 rev 0

DRUG BOTTLE LABEL

Do not use if safety seal is broken
Gabapentin
1-(Aminomethyl)cyclohexaneacetic acid
CAS #60142-96-3
CAUTION: For manufacturing, processing, repacking, or prescription compounding
Net contents: 10.5 g
Repackaged by Fusion Pharmaceuticals, LLC
Camarillo, CA 93012
CS73-A1 rev 0

SUSPENSION BOTTLE LABEL

Do not use if safety seal is broken
For Prescription Compounding Only
Oral Suspension Vehicle
Dye and paraben free
Ingredients: water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, potassium sorbate, sodium benzoate, dibasic sodium phosphate
Net Contents: 420 mL (14.2 fl oz)
Manufactured for:
Fusion Pharmaceuticals, LLC
Camarillo, CA 93012
CS74-A1 rev 0

Carton Box Label

Do not use if safety seal is broken
NDC 43093-105-01
Rx only
FusePaq™  Kit for Oral Suspension
Fanatrex™
(gabapentin 25 mg/mL, in oral suspension - kit)
Description:
This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin. This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.
Active Ingredient:

10.5 g gabapentin, USP


Inactive Ingredients:

420 mL oral suspension vehicle (water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, potassium sorbate, sodium benzoate, dibasic sodium phosphate) Disposable funnel Press-in bottle adaptor for oral dispenser Oral dispenser Instructions


CAUTION: For manufacturing, processing, repacking, or presciption compounding. Federal law prohibits dispensing without prescription.
U.S. Patents Pending
CS72-A1 rev 0



Fanatrex 
gabapentin  kit Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 43093-105 Packaging # NDC Package Description Multilevel Packaging 1 43093-105-01 1 KIT In 1 KIT None QUANTITY OF PARTS Part # Package Quantity Total Product Quantity Part 1 1 BOTTLE, GLASS   10.5 g Part 2 1 BOTTLE, PLASTIC   420 mL Part 1 of 2 GABAPENTIN 
gabapentin  powder, for suspension Product Information       Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Gabapentin (Gabapentin) Gabapentin 10.5 g  in 10.5 g Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 10.5 g In 1 BOTTLE, GLASS None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/15/2010
Part 2 of 2 ORAL SUSPENSION VEHICLE 
suspension  liquid Product Information       Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength No Active Ingredients Found Inactive Ingredients Ingredient Name Strength Water   Banana   N-Acetylglucosamine   Strawberry   ALTHAEA OFFICINALIS LEAF   Glycerin   Stevia Leaf   Acesulfame Potassium   Xanthan Gum   GLYCYRRHIZIN, AMMONIATED   Saccharin Sodium   Potassium Sorbate   Sodium Benzoate   Sodium Phosphate, Dibasic   Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 420 mL In 1 BOTTLE, PLASTIC None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/15/2010
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/15/2010
Labeler - Fusion Pharmaceuticals LLC (021420944) Establishment Name Address ID/FEI Operations Fusion Pharmaceuticals LLC 021420944 manufacture Revised: 05/2010Fusion Pharmaceuticals LLC
More Fanatrex resources Fanatrex Side Effects (in more detail) Fanatrex Use in Pregnancy & Breastfeeding Fanatrex Drug Interactions Fanatrex Support Group 0 Reviews for Fanatrex - Add your own review/rating Compare Fanatrex with other medications Alcohol Withdrawal Anxiety Benign Essential Tremor Bipolar Disorder Burning Mouth Syndrome Diabetic Nerve Damage Epilepsy Erythromelalgia Fibromyalgia Hiccups Hot Flashes Hyperhidrosis Insomnia Migraine Nausea/Vomiting, Chemotherapy Induced Pain Periodic Limb Movement Disorder Peripheral Neuropathy Persisting Pain, Shingles Postmenopausal Symptoms Pruritus Reflex Sympathetic Dystrophy Syndrome Restless Legs Syndrome Trigeminal Neuralgia Vulvodynia
read more


Tylenol Arthritis Pain


acetaminophen
Dosage Form: tablet, film coated, extended release
TYLENOL®
ARTHRITIS
PAIN

Drug Facts

Active ingredient (in each gelcap)

Acetaminophen 650 mg

Purpose

Pain reliever/fever reducer

Uses temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches backache premenstrual and menstrual cramps the common cold headache toothache temporarily reduces fever Warnings Liver warning

This product contains acetaminophen. Severe liver damage may occur if you take

more than 6 gelcaps in 24 hours, which is the maximum daily amount with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product Do not use with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. if you have difficulty swallowing large tablets or capsules. People over 65 may have difficulty swallowing these tablets. if you are allergic to acetaminophen or any of the inactive ingredients in this product

Ask a doctor before use if you have liver disease

Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin

Stop use and ask a doctor if the tablet got stuck in your throat pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days new symptoms occur redness or swelling is present

These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of the reach of children.

Overdose warning

Taking more than the recommended dose (overdose) may cause liver damage. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222) Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Directions do not take more than directed (see overdose warning) adults take 2 gelcaps every 8 hours. Swallow only one gelcap at a time. take a sip of water before swallowing each gelcap and wash each gelcap down with water (up to a full 8 oz glass) swallow whole – do not crush, chew, split or dissolve do not take more than 6 gelcaps in 24 hours do not use for more than 10 days unless directed by a doctor under 18 years of age ask a doctor Other information store at 20–25°C (68–77°F). Avoid high humidity. do not use if carton is opened or neck wrap or foil inner seal imprinted with "Safety Seal®" is broken see end panel for lot number and expiration date Inactive ingredients

benzyl alcohol, butylparaben, castor oil, corn starch, edetate calcium disodium, FD&C blue #1 aluminum lake, FD&C blue #2 aluminum lake, gelatin, hydroxyethyl cellulose, hypromellose, magnesium stearate, methylparaben, microcrystalline cellulose, povidone, powdered cellulose, pregelatinized starch, propylene glycol, propylparaben, shellac, sodium lauryl sulfate, sodium propionate, sodium starch glycolate, titanium dioxide

Questions or comments?

call 1-877-895-3665

PRINCIPAL DISPLAY PANEL

See New Warnings Information

NDC 50580-508-20

Push
& Turn
Cap

TYLENOL®

ARTHRITIS
PAIN
Acetaminophen Extended Release Pain Reliever/Fever Reducer
For The Temporary Relief Of Minor Arthritis Pain

20 GELCAPS-650 mg each

Gelcaps*
*Gelatin-Coated Capsule-Shaped Tablets


TYLENOL   ARTHRITIS PAIN
acetaminophen  tablet, film coated, extended release Product Information Product Type HUMAN OTC DRUG NDC Product Code (Source) 50580-508 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Acetaminophen (Acetaminophen) Acetaminophen 650 mg Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found Product Characteristics Color WHITE Score no score Shape OVAL Size 19mm Flavor Imprint Code Tylenol;Arthritis;650 Contains          Packaging # NDC Package Description Multilevel Packaging 1 50580-508-20 1 BOTTLE In 1 CARTON contains a BOTTLE, PLASTIC 1 20 TABLET In 1 BOTTLE, PLASTIC This package is contained within the CARTON (50580-508-20) 2 50580-508-40 1 BOTTLE In 1 CARTON contains a BOTTLE, PLASTIC 2 40 TABLET In 1 BOTTLE, PLASTIC This package is contained within the CARTON (50580-508-40) 3 50580-508-80 1 BOTTLE In 1 CARTON contains a BOTTLE, PLASTIC 3 80 TABLET In 1 BOTTLE, PLASTIC This package is contained within the CARTON (50580-508-80)
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA019872 01/01/2010
Labeler - McNeil Consumer Healthcare Div McNeil-PPC, Inc (878046358) Revised: 11/2009McNeil Consumer Healthcare Div McNeil-PPC, Inc
More Tylenol Arthritis Pain resources Tylenol Arthritis Pain Side Effects (in more detail) Tylenol Arthritis Pain Dosage Tylenol Arthritis Pain Use in Pregnancy & Breastfeeding Drug Images Tylenol Arthritis Pain Drug Interactions Tylenol Arthritis Pain Support Group 1 Review for Tylenol Arthritis Pain - Add your own review/rating Compare Tylenol Arthritis Pain with other medications Fever Muscle Pain Pain Sciatica
read more


E45 Cream (Forum Health Products Limited )


1. Name Of The Medicinal Product

E45 Cream

2. Qualitative And Quantitative Composition

Anhydrous Lanolin

 

1.0%

w/w

White Soft Paraffin

BP

14.5%

w/w

Light Liquid Paraffin

PhEur

12.6%

w/w

3. Pharmaceutical Form

A cream

4. Clinical Particulars 4.1 Therapeutic Indications

For the symptomatic relief of dry skin conditions, where the use of an emollient is indicated, such as flaking, chapped skin, ichthyosis, traumatic dermatitis, sunburn, the dry stage of eczema and certain dry cases of psoriasis.

4.2 Posology And Method Of Administration

For topical application.

Adults, Children, Babies and the Elderly - Apply to the affected part two or three times daily.

4.3 Contraindications

Hypersensitivity to any of the ingredients.

4.4 Special Warnings And Precautions For Use

The labelling states:

For external use only.

If symptoms persist, consult your doctor.

Keep all medicines out of the reach of children.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

No clinically significant interactions known.

4.6 Pregnancy And Lactation

The safety of E45 Cream in pregnancy and lactation has not been assessed but is thought unlikely to constitute a hazard.

4.7 Effects On Ability To Drive And Use Machines

No adverse effects known.

4.8 Undesirable Effects

Occasionally, hypersensitivity reactions, otherwise adverse effects are unlikely, but should they occur, may take the form of an allergic rash. Should this occur, use of the product should be discontinued.

4.9 Overdose

E45 cream is of low toxicity. If accidental ingestion occurs, conservative treatment only is required.

5. Pharmacological Properties 5.1 Pharmacodynamic Properties

Lanolin, light liquid paraffin and white soft paraffin have emollient moisturising properties.

5.2 Pharmacokinetic Properties

Not applicable.

5.3 Preclinical Safety Data

There are no pre-clinical safety data of relevance to the consumer.

6. Pharmaceutical Particulars 6.1 List Of Excipients

Empilan GMS, cetyl alcohol, sodium cetostearyl sulphate, carbomer, methyl hydroxybenzoate, propyl hydroxybenzoate, sodium hydroxide, citric acid monohydrate, purified water.

6.2 Incompatibilities

Compatibility problems may be encountered with the stronger acids, calcium, magnesium and aluminium salts, quaternary compounds, acridines, basic dyestuffs and alkaloids.

6.3 Shelf Life

Aluminium tubes and polypropylene tubs: 3 years.

All other containers: 2 years.

6.4 Special Precautions For Storage

Store below 25°C for polyethylene tubes and pump pack, made of polypropylene and polyethylene and consisting of a plastic bottle and a pump system with a dip tube. None for aluminium tubes and polypropylene tubs.

6.5 Nature And Contents Of Container

A collapsible aluminium tube, internally lacquered with a membrane seal and plastic screw cap. Pack sizes: 15, 50 or 100 g.

(The 100 g tube is for dispensing only. One hundred tubes will be packed in an outer carton, labelled with the same wording as an OTC pack and the additional statement 'For dispensing only - not for retail sale'.)

A polyethylene tube with membrane seal and plastic screw cap. Pack sizes 15 or 50 g.

A polypropylene securipot with a white polythene pilfer-proof screw cap. Pack sizes: 125, 350 or 500 g.

A white polypropylene jar with a white polyethylene push-on, tamper-evident closure. Pack sizes: 250, 300 or 500 g.

((The 500 g jar is for dispensing only. Thirty-six jars will be packed in an outer carton, labelled with the same wording as an OTC pack and the additional statement 'For dispensing only - not for retail sale'.)

A polypropylene securipot with a polythene pilfer-proof screw cap fitted with a HDPE or polypropylene dispenser having a polythene covered follower plate.

Pack sizes: 500 or 900 g.

A pump pack made of polypropylene and polyethylene, consisting of a plastic bottle and a pump system with a dip tube. Pack size: 500 g.

A pump pack made of polypropylene and polyethylene, consisting of a piston pump system with an airless dispenser. Pack size: 500g

Not all pack sizes are necessarily marketed.

6.6 Special Precautions For Disposal And Other Handling

None.

7. Marketing Authorisation Holder

Reckitt Benckiser Healthcare (UK) Limited

Wellcroft Road

Slough,

SL1 4AQ

United Kingdom

8. Marketing Authorisation Number(S)

PL 00063/0404

9. Date Of First Authorisation/Renewal Of The Authorisation

25th September 1991

10. Date Of Revision Of The Text

07/10/2011

11 DOSIMETRY

IF APPLICABLE

12 INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS

IF APPLICABLE


read more


Lamisil AT


terbinafine hydrochloride
Dosage Form: cream
Drug Facts Active ingredient

Terbinafine hydrochloride

Purpose

Antifungal

Uses cures most athlete’s foot (tinea pedis) cures most jock itch (tinea cruris) and ringworm (tinea corporis) relieves itching, burning, cracking and scaling which accompany these conditions Warnings

For external use only

Do Not Use on nails or scalp in or near the mouth or eyes for vaginal yeast infections When using this product

do not get into eyes. If eye contact occurs, rinse thoroughly with water.

Stop use and ask doctor

if too much irritation occurs or gets worse

Keep out of reach of children

If swallowed, get medical help or contact a poison control center right away.

Directions

• adults and children 12 years and over:

    • use the tip of the cap to break the seal and open the tube

    • wash the affected skin with soap and water and dry completely before applying

    • for athlete’s foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily

        • between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor

1 week between the toes

       • on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor

2 weeks on the bottom or sides of the foot

    • for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor

    • wash hands after each use

• children under 12 years: ask a doctor

Other information do not use if seal on tube is broken or is not visible store at controlled room temperature 20-25°C (68-77°F) Inactive ingredients

benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

Questions

call 1-800-452-0051

Novartis Consumer Health, Inc.

Parsippany, NJ 07054-0622 ©2008

Principal display panel

Lamisil AT Cream


LAMISIL  AT
terbinafine hydrochloride  cream Product Information Product Type HUMAN OTC DRUG NDC Product Code (Source) 0067-3998 Route of Administration TOPICAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TERBINAFINE HYDROCHLORIDE (TERBINAFINE) TERBINAFINE HYDROCHLORIDE 10 mg  in 1 g Inactive Ingredients Ingredient Name Strength BENZYL ALCOHOL   CETYL ALCOHOL   CETYL PALMITATE   ISOPROPYL MYRISTATE   POLYSORBATE 60   WATER   SODIUM HYDROXIDE   SORBITAN MONOSTEARATE   STEARYL ALCOHOL   Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 0067-3998-42 1 TUBE In 1 CARTON contains a TUBE 1 12 g In 1 TUBE This package is contained within the CARTON (0067-3998-42) 2 0067-3998-30 1 TUBE In 1 CARTON contains a TUBE 2 30 g In 1 TUBE This package is contained within the CARTON (0067-3998-30) 3 0067-3998-99 42 g In 1 CARTON None
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA020980 08/10/2005
Labeler - Novartis Consumer Health, Inc. (879821635) Revised: 01/2010Novartis Consumer Health, Inc.
More Lamisil AT resources Lamisil AT Side Effects (in more detail) Lamisil AT Use in Pregnancy & Breastfeeding Lamisil AT Support Group 4 Reviews for Lamisil AT - Add your own review/rating Lamisil AT Concise Consumer Information (Cerner Multum) Lamisil AT Topical Advanced Consumer (Micromedex) - Includes Dosage Information Lamisil AT Cream MedFacts Consumer Leaflet (Wolters Kluwer) Compare Lamisil AT with other medications Tinea Corporis Tinea Cruris Tinea Pedis
read more


Boots Nirolex Chesty Cough & Congestion Relief Linctus


Boots Nirolex Chesty Cough & Congestion Relief Linctus (Guaifenesin, Pseudoephedrine Hydrochloride)

Non drowsy

Relieves chesty coughs

Clears nasal congestion

120 ml e

Read all of this carton for full instructions.

What this medicine is for

This medicine contains Guaifenesin and Pseudoephedrine Hydrochloride, which act to relieve coughs and blocked noses.

It can be used to relieve the symptoms of chesty coughs, catarrh and blocked noses, without causing drowsiness.

Before you take this medicine Do not take: If you are allergic to any of the ingredients If you have heart or blood vessel disease, high blood pressure (including that due to a tumour near your kidney), glaucoma If you have severe kidney problems, diabetes, an overactive thyroid If you are taking monoamine oxidase inhibitors (for depression) or have taken them in the last 14 days If you have an intolerance to some sugars, unless your doctor tells you to (this medicine contains sucrose) If you are a man with prostate problems If you are pregnant Talk to your pharmacist or doctor: If you have other kidney problems (see above) If you take other medicines tricyclic antidepressants digoxin (for heart problems) medicines for high blood pressure other decongestants appetite suppressants or stimulants If you are breastfeeding Information about some of the ingredients:

The colour carmoisine (E122) in this medicine may cause allergic reactions.

How to take this medicine

Check the seal is not broken before first use. If it is, do not take the medicine.

Adults and children of 12 years and over
Take two 5ml spoonfuls 4 times a day.

Children of 6 to 11 years
Take one 5ml spoonful 3 times a day.

This medicine should be swallowed.

Do not give to children under 6 years.

Warning: Do not exceed the stated dose

If symptoms do not go away talk to your doctor.

If you take too much: Talk to doctor straight away.

Possible side effects

Most people will not have problems, but some may get some of these:

Feeling sick, being sick, stomach discomfort Headache Irritability, restlessness, confusion, shaking, difficulty sleeping, dizziness Fast heart beat, heart rhythm problems, palpitations, high blood pressure Difficulty in passing urine Skin rashes

If any side effect becomes severe, or you notice any side effect not listed here, please tell your pharmacist or doctor.

How to store this medicine

Do not store above 30°C.

Keep all medicines out of the sight and reach of children.

Use by the date on the end flap of the carton.

Active ingredients

Each 5 ml of oral solution contains Guaifenesin 100 mg, Pseudoephedrine Hydrochloride 30 mg.

Also contains: purified water, liquid sugar (sucrose), glycerol (E422), citric acid, sodium citrate, hyetellose, potassium sorbate (E202), acesulfame potassium, carmoisine (E122), patent V (E131), flavours (strawberry, blackcurrant, menthol, cream).

PL 00014/0555 [P]

Text prepared 11/07

Manufactured by the Marketing Authorisation holder The Boots Company PLC Nottingham England NG2 3AA Other formats

To request a copy of this carton in Braille, large print or audio please call, free of charge:

0800 198 5000 (UK only)

Please be ready to give the following information:

Product name: Boots Nirolex Chesty Cough & Congestion Relief Linctus

Reference number: 00014/0555

This is a service provided by the Royal National Institute of the Blind.

If you need more advice ask your pharmacist.

BTC 23038 vD 28/03/08


read more


Brulidine Cream


1. Name Of The Medicinal Product

Brulidine Cream

Lloyds Antiseptic Cream

2. Qualitative And Quantitative Composition

Dibrompropamidine isethionate 0.15%w/w

3. Pharmaceutical Form

Cream

4. Clinical Particulars 4.1 Therapeutic Indications

Indications

(a) First aid dressing for minor burns, scalds, abrasions and other open injuries and their routine treatment

(b) For the treatment of surface infections due to susceptible organisms, particularly in cases with penicillin resistant Staphylococci or certain Gram-negative bacilli

(c) Treatment of ringworm of the scalp (Microsporum canis) and other superficial fungal infections

(d) Treatment of pyodermias, including sycosis barbae

(e) Treatment of otitis externa

(f) Treatment of nappy rash

4.2 Posology And Method Of Administration

Adults: apply to the affected area, either directly or on a light dressing, two or three times a day.

Elderly and children: no specific recommendations.

4.3 Contraindications

Brulidine Cream should not be used in patients with known hypersensitivity to dibrompropamidine or any of the other ingredients.

4.4 Special Warnings And Precautions For Use

Prolonged use may interfere with healing and cause skin necrosis in infants.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

None known

4.6 Pregnancy And Lactation

There is no evidence of the drug's safety in human use nor is there any evidence from animal work that it is free from hazard. Avoid unless considered essential.

4.7 Effects On Ability To Drive And Use Machines

None

4.8 Undesirable Effects

There is always the possibility, although rare, of a sensitisation reaction or contact dermatitis occurring: in such an event, treatment should be discontinued immediately.

4.9 Overdose

The 25g tube of Brulidine Cream contains 37.5mg of dibrompropamidine and the 30g contains 45mg.

No toxic effects are likely to occur even if the contents of a full tube are accidentally ingested. Similarly, the ingredients of the base are unlikely to have toxic effects in the quantities present.

5. Pharmacological Properties 5.1 Pharmacodynamic Properties

Dibrompropamidine isethionate is an antibacterial agent active against pathogenic Streptococci and Staphylococci, including penicillin resistant strains, and has some activity against a number of Gram negative bacilli. Its antibacterial action in not inhibited by pus, blood or p-aminobenzoic acid. In addition, it has useful activity against certain species of pathogenic fungi. Brulidine Cream is well tolerated and rarely gives rise to sensitisation reactions or contact dermatitis.

5.2 Pharmacokinetic Properties

No data available

5.3 Preclinical Safety Data

No relevant data

6. Pharmaceutical Particulars 6.1 List Of Excipients

Caster oil, virgin

Cetostearyl alcohol

Polyethylene glycol 600 monostearate

Methyl parahydroxybenzoate

Silicone MS antifoam A

Purified water

6.2 Incompatibilities

Not applicable

6.3 Shelf Life

36 months

6.4 Special Precautions For Storage

Store below 25°C

6.5 Nature And Contents Of Container

Collapsible aluminium internally lacquered tube with extended nozzle containing 25g or 30g cream

Polythene plug seal cap

6.6 Special Precautions For Disposal And Other Handling

Not applicable

7. Marketing Authorisation Holder

Manx Pharma Ltd

Taylor Group House

Wedgnock Lane

Warwick

CV34 5YA

United Kingdom

8. Marketing Authorisation Number(S)

PL 15833/0002

9. Date Of First Authorisation/Renewal Of The Authorisation

1 September 1997 / 30 May 2002

10. Date Of Revision Of The Text

September 2010


read more


Meggezones


1. Name Of The Medicinal Product

Meggezones

2. Qualitative And Quantitative Composition

Each pastille contains menthol 16.0mg BP

3. Pharmaceutical Form

Pastille.

4. Clinical Particulars 4.1 Therapeutic Indications

Symptomatic relief of sore throats, coughs, colds, catarrh and nasal congestion.

4.2 Posology And Method Of Administration

Allow one pastille to dissolve slowly in the mouth as required.

Maximum daily dose : Adults - 15 pastilles; children aged 6 to 12 years - 10 pastilles; children aged under 6 years - 5 pastilles.

4.3 Contraindications

None known.

4.4 Special Warnings And Precautions For Use

Hypersensitivity to the product is a possible side effect. Contact dermatitis may occur with menthol products.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

None known.

4.6 Pregnancy And Lactation

Safety in pregnancy and lactation has not been established. However menthol-containing products have been used for many years with no ill effect.

4.7 Effects On Ability To Drive And Use Machines

None known.

4.8 Undesirable Effects

None stated.

4.9 Overdose

Systemic effects due to overdosage are most unlikely.

5. Pharmacological Properties 5.1 Pharmacodynamic Properties

Menthol in pastille formulation relieves catarrh and other symptoms associated with colds.

5.2 Pharmacokinetic Properties

Menthol is excreted in the urine and bile as a glucuronide.

5.3 Preclinical Safety Data

There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.

6. Pharmaceutical Particulars 6.1 List Of Excipients

Modified starch, antifoam 1510, sucrose, liquorice extract powder, liquid glucose (80%) solid (1963); peppermint oil; benzoin; water.

6.2 Incompatibilities

None known.

6.3 Shelf Life

24 months.

6.4 Special Precautions For Storage

Once opened keep in a cool dry place.

6.5 Nature And Contents Of Container

PVC blister packs with aluminium seal in a cardboard box. Packs contain 3, 8, 24, 36 or 48 pastilles.

6.6 Special Precautions For Disposal And Other Handling

Not applicable.

7. Marketing Authorisation Holder

Schering-Plough Ltd

Shire Park

Welwyn Garden City

Hertfordshire

AL7 1TW

UK

8. Marketing Authorisation Number(S)

PL 0201/0104

9. Date Of First Authorisation/Renewal Of The Authorisation

5 May 1988 / 5 May 1993

10. Date Of Revision Of The Text

November 1998

11. Legal Status

GSL

Meggezones/UK/02-10/1


read more


Apomorphine Hydrochloride


Dosage Form: pellet
APOMORPHINUM MURIATICUM 3X (Apomorphine Hydrochloride) Free from yeast, wheat, corn, and soy.
DIRECTIONS: Dissolve 3 or 4 pellets
in mouth or under tongue 3 times a day or as directed by a physician.
Children 2 years and older take 1/2
adult dose.
INDICATIONS: To be used according
to standard homeopathic indications
for self limiting conditions such as
those indicated on the front panel or as directed by a physician.
Warnings: *Use only if cap and
seal are unbroken. * Keep this and all medications out of reach of children.
* If symptoms persist for more then 3
days, consult your physician.
*As with any drug, if your are pregnant or nursing a baby, seek the advice of a
health professional before using this product.*Store tightly closed in a cool, dark place.
Made according to The Homoeopathic Pharmacopoeia of the United States by: Remedy Makers, Pomona, CA 91768


APOMORPHINUM MURIATICUM 
Apomorphine Hydrochloride  pellet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 10191-1225 Route of Administration SUBLINGUAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Apomorphine Hydrochloride (APOMORPHINE ) Apomorphine Hydrochloride 3 [hp_X] Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 10191-1225-2 153 PELLET In 1 VIAL, GLASS None
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved homeopathic 03/18/2002
Labeler - Remedy Makers (018543582) Revised: 12/2009Remedy Makers
More Apomorphine Hydrochloride resources Apomorphine Hydrochloride Side Effects (in more detail) Apomorphine Hydrochloride Use in Pregnancy & Breastfeeding Apomorphine Hydrochloride Drug Interactions Apomorphine Hydrochloride Support Group 4 Reviews for Apomorphine Hydrochloride - Add your own review/rating Apomorphine Hydrochloride Monograph (AHFS DI) Apokyn Advanced Consumer (Micromedex) - Includes Dosage Information Apokyn MedFacts Consumer Leaflet (Wolters Kluwer) Apokyn Consumer Overview Compare Apomorphine Hydrochloride with other medications Parkinson's Disease Tardive Dyskinesia
read more


Boots Pharmacy Cold & Flu Night Liquid


Boots Pharmacy Cold & Flu Night Liquid

Specifically to: Give full strength dose of paracetamol Relieve congestion and reduce coughing Relieve fever, aches and pains Aid restful sleep

240 ml e

Read all of this carton for full instructions.

This medicine is made specially for night-time and contains a combination of ingredients to give you relief from the major symptoms of colds and flu. It relieves fever, aches and pains, nasal congestion, dry, tickly coughs and helps you sleep.

Before you take this medicine

Contains Paracetamol
Do not take with any other paracetamol-containing products.
Immediate medical advice should be sought in the event of an overdose, even if you feel well, because of the risk of delayed, serious liver damage.

Warning: May cause drowsiness. If affected, do not drive or operate machinery. Avoid alcoholic drink.

Do not take: If you are allergic to any of the ingredients If you have heart disease or have high blood pressure (including that due to a tumour near your kidneys) If you suffer from diabetes, an overactive thyroid, glaucoma If you suffer from severe kidney disease, liver failure, long term lung problems e.g. bronchitis or bronchiectasis If you are taking monoamine oxidase inhibitors (for depression) or have taken them within the last 14 days If you have an intolerance to some sugars, unless your doctor tells you to (this medicine contains maltitol liquid) If you are a man with prostate problems If you are pregnant or breastfeeding Talk to your pharmacist or doctor: If you have asthma If you have other kidney or liver problems (including a disease caused by drinking alcohol) If you are on a controlled sodium diet (each 30 ml contains 33 mg of sodium) If you take other medicines Medicines for heart problems (e.g. digoxin) Medicines for high blood pressure Barbiturates (for epilepsy) Sleeping tablets Strong pain killers, sedatives, tranquillisers, tricyclic antidepressants Atropine Metoclopramide or domperidone (for feeling sick) Colestyramine (to reduce blood fat levels) Warfarin or other blood thinners If you suffer from alcoholism, epilepsy, brain injury or disease (this medicine contains alcohol which may be harmful to you)

Do not drink alcohol (wine, beers, spirits) whilst taking this medicine (propylene glycol may enhance the effects of alcohol).

Information about some of the ingredients:

Each 30 ml contains 1169 mg of alcohol (ethanol) equivalent to 29 ml of beer or 12 ml of wine.

Glycerol may cause headache, stomach upset and diarrhoea.

How to take this medicine

Check the seal is not broken before first use. If it is, do not take the medicine.

Take at bedtime only. Use the measuring cup provided.

Adults and children of 12 years and over

Take 30 ml

At bedtime only

This medicine should be swallowed

Do not give to children under 12 years.

Warning:

Do not exceed stated dose.

Do not take this medicine for more than 7 days unless your doctor tells you to.

If symptoms persist consult your doctor.

Possible side effects

Most people will not have problems, but some may get some.

If you get any of these serious side effects, stop taking the medicine.

See a doctor at once: Difficulty in breathing, swelling of the face, neck, tongue or throat (severe allergic reactions) These other effects are less serious.

If they bother you talk to a pharmacist:

Drowsiness, tiredness, dizziness, muscular weakness Feeling sick, being sick, diarrhoea, constipation, stomach upset, stomach pains Headache, blurred vision, ringing in the ears, loss of appetite Irritability, nightmares, hallucinations (particularly in children) Fast heart rate, shaking, difficulty in passing urine, dry mouth, phlegm on the chest, sweating Skin rash Unusual bruising or infections such as sore throats – this may be a sign of very rare changes in the blood.

If any side effect becomes severe, or you notice any side effect not listed here, please tell your pharmacist or doctor.

How to store this medicine

Do not store above 25°C.

Keep all medicines out of the sight and reach of children.

Use by the date on the end flap of the carton.

Active ingredients

Each 30 ml of oral solution contains Diphenhydramine Hydrochloride 25 mg, Paracetamol 1000 mg, Pholcodine 10 mg, Pseudoephedrine Hydrochloride 60 mg.

Also contains: glycerol (E422), propylene glycol, maltitol liquid (E965), purified water, ethanol (4.8 vol %), citric acid, sodium citrate, sodium benzoate (E211), acesulfame potassium, quinoline yellow (E104), patent blue V (E131), flavours (peppermint, aniseed (containing benzyl alcohol, propylene glycol)).

PL 00014/0571

P

Text prepared 3/08

Manufactured for the Marketing Authorisation holder Boots Pharmacy Nottingham NG2 3AA

by

The Boots Company PLC Nottingham NG2 3AA

If you need more advice ask your pharmacist.

BTC19179 vF 28/08/08


read more


Lugols Strong Iodine Solution



Dosage Form: solution
Lugols Strong Iodine Solution CONTENTS      

Iodine 0.05 g/ml, Potassium Iodide 0.105 g/ml.

DESCRIPTION      

LUGOL’S is an aqueous solution containing Iodine 5%, and potassium iodide 10%, w/v (LUGOL’s Solution). LUGOL’s is a transparent liquid with a deep brown color and the odor of iodine.

HOW SUPPLIED      

LUGOL’S is supplied in 8 ml glass single-use bottles.

INDICATIONS AND USAGE      

LUGOL’s is a topical antiseptic. Strong Iodine Solution is a germicide and fungicide. LUGOL’s is preservative-free.

ADMINISTRATION      

LUGOL’S is applied directly to areas needing antiseptic.

WARNINGS      

For External Use Only.

CONTRAINDICATIONS      

Iodide preparations are contraindicated in patients with known sensitivity to the drugs.

CAUTION      

Federal law restricts this device to sale by or on the order of a physician.

STORAGE      

Keep tightly closed. Protect from light.  DO NOT use if seal has been broken. Store at controlled room temperature 15°-30°C (59°-86°F).

DISPOSAL      

Opened containers with unused portions of product and applicator swabs containing residual product should be placed in a suitable, dry container for disposal following local hazardous waste practices. Waste containing LUGOL’S should not be subjected to any thermal process whether intended for destruction or recycling purposes.

PRINCIPAL DISPLAY PANEL

Lugol’s

Strong Iodine Solution USP

Contents      

One Dozen (12)

8ml Vials


LUGOLS STRONG IODINE 
iodine potassium iodide  solution Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 59365-6064 Route of Administration TOPICAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength IODINE (IODINE) IODINE 0.05 g  in 1 mL POTASSIUM IODIDE (POTASSIUM CATION) POTASSIUM IODIDE 0.105 g  in 1 mL Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 59365-6064-1 12 VIAL In 1 CARTON contains a VIAL, SINGLE-USE 1 8 mL In 1 VIAL, SINGLE-USE This package is contained within the CARTON (59365-6064-1)
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date UNAPPROVED DRUG OTHER 10/01/1992
Labeler - CooperSurgical, Inc. (801895244) Revised: 11/2009CooperSurgical, Inc.
More Lugols Strong Iodine Solution resources Lugols Strong Iodine Solution Drug Interactions Lugols Strong Iodine Solution Support Group 0 Reviews · Be the first to review/rate this drug
read more


Gelato Chlorhexidine Rinse


Generic Name: chlorhexidine gluconate
Dosage Form: oral rinse
Gelato Chlorhexidine Distilled Water, Glycerin, Polysorbate 20, Poloxamer 407, Sodium Saccharin, Mint Flavor, FD and C Blue #1

The effect of Chlohexidrine Gluconate Oral Rinse on periodontitis has not been determined. An increase in supragingival calculus was not noted in clinical testing in chlohexidine gluconate oral rinse users compared with control users. It is not known if Chlorhexidine Gluconate oral rinse use results in an increase in subgingival calculus. Calculus deposits should be removed by a dental prophylaxis at intervals not greater than six months. Hypersensitivity and generalized allergic reactions have occured. read CONTRAINDICATIONS indicated on the insert inside the box.

To open, press down while turning cap. To seal, turn until cap clicks and is tight. Fill dosage cup to the fill like (150ml). Swish in your mouth undiluted for 30 seconds, the spit out. Use after breakfast and before bedtime. Or, use as prescribed by your dentist.

Chlorhexidine Gluconate Oral Rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. For patients having coexisting gingivitis and periodontitis, read PRECAUTIONS indicated on the insert inside the box.

Store at controlled room temperature 68-77F (20-25C). Protect from freezing.

0.12% Chlorhexidine Gluconate

Antigingivitis


GELATO CHLOROHEXIDINE 
chlorhexidine gluconate  rinse Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 68400-500 Route of Administration DENTAL, TOPICAL, ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CHLORHEXIDINE GLUCONATE (CHLORHEXIDINE) CHLORHEXIDINE GLUCONATE 56.76 mL  in 473 mL Inactive Ingredients Ingredient Name Strength Water   Glycerin   FD&C BLUE NO. 1   SACCHARIN SODIUM   POLYSORBATE 20   POLOXAMER 407   Product Characteristics Color      Score      Shape Size Flavor MINT Imprint Code Contains          Packaging # NDC Package Description Multilevel Packaging 1 68400-500-16 473 mL In 1 BOTTLE None
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 03/31/2010
Labeler - Deepak Products, inc. (124886743) Establishment Name Address ID/FEI Operations Deepak Products, inc. 124886743 manufacture Revised: 04/2011Deepak Products, inc.
More Gelato Chlorhexidine Rinse resources Gelato Chlorhexidine Rinse Side Effects (in more detail) Gelato Chlorhexidine Rinse Use in Pregnancy & Breastfeeding Gelato Chlorhexidine Rinse Support Group 1 Review for Gelato Chlorhexidine - Add your own review/rating Compare Gelato Chlorhexidine Rinse with other medications Gingivitis Mucositis Periodontitis
read more


Mucinex D Maximum Strength



Dosage Form: tablet, extended release
Mucinex®D

Drug Facts

Active ingredients (in each extended-release bi-layer tablet) Purpose Guaifenesin 1200 mg Expectorant Pseudoephedrine HCl 120 mg Nasal Decongestant Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves nasal congestion due to: common cold hay fever upper respiratory allergies temporarily restores freer breathing through the nose promotes nasal and/or sinus drainage temporarily relieves sinus congestion and pressure Warnings

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

heart disease high blood pressure thyroid disease diabetes trouble urinating due to an enlarged prostate gland persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema cough accompanied by too much phlegm (mucus)

When using this product

do not use more than directed

Stop use and ask a doctor if

you get nervous, dizzy, or sleepless symptoms do not get better within 7 days, come back or occur with a fever, rash, or persistent headache. These could be signs of a serious illness.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions do not crush, chew, or break tablet take with a full glass of water this product can be administered without regard for timing of meals adults and children 12 years and older: 1 tablet every 12 hours; not more than 2 tablets in 24 hours children under 12 years of age: do not use Other information tamper evident: do not use if carton is open or if printed seal on blister is broken or missing store at 20-25°C (68-77°F) Inactive ingredients

carbomer 934P, NF; FD&C yellow #6 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF

Distributed by:
Reckitt Benckiser Inc.
Parsippany, NJ 07054-0224
©RBI 2009

PRINCIPAL DISPLAY PANEL - 1200 mg Carton

MAXIMUM STRENGTH

NDC 63824-041-24

Mucinex®D

1200 mg guaifenesin & 120 mg pseudoephedrine HCl
extended-release bi-layer tablets

EXPECTORANT & NASAL DECONGESTANT

12 HOUR

NEW LOOK-
SAME RELIEF

Thins And Loosens Mucus

Clears Nasal/Sinus Congestion

24 EXTENDED-RELEASE BI-LAYER TABLETS


MUCINEX D   MAXIMUM STRENGTH
guaifenesin and pseudoephedrine hydrochloride  tablet, extended release Product Information Product Type HUMAN OTC DRUG NDC Product Code (Source) 63824-041 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Guaifenesin (Guaifenesin) Guaifenesin 1200 mg Pseudoephedrine Hydrochloride (Pseudoephedrine) Pseudoephedrine Hydrochloride 120 mg Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found Product Characteristics Color ORANGE, WHITE Score no score Shape OVAL Size 22mm Flavor Imprint Code Mucinex;1200 Contains          Packaging # NDC Package Description Multilevel Packaging 1 63824-041-24 3 BLISTER PACK In 1 CARTON contains a BLISTER PACK 1 8 TABLET In 1 BLISTER PACK This package is contained within the CARTON  (63824-041-24)
Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021585 04/17/2009
Labeler - Reckitt Benckiser, Inc. (094405024) Revised: 12/2009Reckitt Benckiser, Inc.
More Mucinex D Maximum Strength resources Mucinex D Maximum Strength Side Effects (in more detail) Mucinex D Maximum Strength Use in Pregnancy & Breastfeeding Drug Images Mucinex D Maximum Strength Drug Interactions Mucinex D Maximum Strength Support Group 58 Reviews for Mucinex D Maximum Strength - Add your own review/rating Compare Mucinex D Maximum Strength with other medications Cough and Nasal Congestion
read more


Related Search: